Psoriasis Treatment
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Pseudotumor Cerebri Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudotumor Cerebri Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Fundoscopy
1.2.3 Neuroimaging
1.2.4 Lumbar Puncture
1.3 Market by Application
1.3.1 Global Pseudotumor Cerebri Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Spinal Fluid Shunt
1.3.3 Optic Nerve Sheath Fenestration
1.3.4 Venous Sinus Stenting
1.3.5 Medication
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pseudotumor Cerebri Market Perspective (2017-2028)
2.2 Pseudotumor Cerebri Growth Trends by Region
2.2.1 Pseudotumor Cerebri Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pseudotumor Cerebri Historic Market Size by Region (2017-2022)
2.2.3 Pseudotumor Cerebri Forecasted Market Size by Region (2023-2028)
2.3 Pseudotumor Cerebri Market Dynamics
2.3.1 Pseudotumor Cerebri Industry Trends
2.3.2 Pseudotumor Cerebri Market Drivers
2.3.3 Pseudotumor Cerebri Market Challenges
2.3.4 Pseudotumor Cerebri Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pseudotumor Cerebri Players by Revenue
3.1.1 Global Top Pseudotumor Cerebri Players by Revenue (2017-2022)
3.1.2 Global Pseudotumor Cerebri Revenue Market Share by Players (2017-2022)
3.2 Global Pseudotumor Cerebri Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pseudotumor Cerebri Revenue
3.4 Global Pseudotumor Cerebri Market Concentration Ratio
3.4.1 Global Pseudotumor Cerebri Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudotumor Cerebri Revenue in 2021
3.5 Pseudotumor Cerebri Key Players Head office and Area Served
3.6 Key Players Pseudotumor Cerebri Product Solution and Service
3.7 Date of Enter into Pseudotumor Cerebri Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pseudotumor Cerebri Breakdown Data by Type
4.1 Global Pseudotumor Cerebri Historic Market Size by Type (2017-2022)
4.2 Global Pseudotumor Cerebri Forecasted Market Size by Type (2023-2028)
5 Pseudotumor Cerebri Breakdown Data by Application
5.1 Global Pseudotumor Cerebri Historic Market Size by Application (2017-2022)
5.2 Global Pseudotumor Cerebri Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pseudotumor Cerebri Market Size (2017-2028)
6.2 North America Pseudotumor Cerebri Market Size by Country (2017-2022)
6.3 North America Pseudotumor Cerebri Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pseudotumor Cerebri Market Size (2017-2028)
7.2 Europe Pseudotumor Cerebri Market Size by Country (2017-2022)
7.3 Europe Pseudotumor Cerebri Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pseudotumor Cerebri Market Size (2017-2028)
8.2 Asia-Pacific Pseudotumor Cerebri Market Size by Country (2017-2022)
8.3 Asia-Pacific Pseudotumor Cerebri Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pseudotumor Cerebri Market Size (2017-2028)
9.2 Latin America Pseudotumor Cerebri Market Size by Country (2017-2022)
9.3 Latin America Pseudotumor Cerebri Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pseudotumor Cerebri Market Size (2017-2028)
10.2 Middle East & Africa Pseudotumor Cerebri Market Size by Country (2017-2022)
10.3 Middle East & Africa Pseudotumor Cerebri Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Avkare, Inc.
11.1.1 Avkare, Inc. Company Detail
11.1.2 Avkare, Inc. Business Overview
11.1.3 Avkare, Inc. Pseudotumor Cerebri Introduction
11.1.4 Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.1.5 Avkare, Inc. Recent Development
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Detail
11.2.2 B. Braun Melsungen AG Business Overview
11.2.3 B. Braun Melsungen AG Pseudotumor Cerebri Introduction
11.2.4 B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2017-2022)
11.2.5 B. Braun Melsungen AG Recent Development
11.3 Beckersmith Medical, Inc.
11.3.1 Beckersmith Medical, Inc. Company Detail
11.3.2 Beckersmith Medical, Inc. Business Overview
11.3.3 Beckersmith Medical, Inc. Pseudotumor Cerebri Introduction
11.3.4 Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.3.5 Beckersmith Medical, Inc. Recent Development
11.4 Elekta AB
11.4.1 Elekta AB Company Detail
11.4.2 Elekta AB Business Overview
11.4.3 Elekta AB Pseudotumor Cerebri Introduction
11.4.4 Elekta AB Revenue in Pseudotumor Cerebri Business (2017-2022)
11.4.5 Elekta AB Recent Development
11.5 Heritage Pharmaceuticals Inc.
11.5.1 Heritage Pharmaceuticals Inc. Company Detail
11.5.2 Heritage Pharmaceuticals Inc. Business Overview
11.5.3 Heritage Pharmaceuticals Inc. Pseudotumor Cerebri Introduction
11.5.4 Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.5.5 Heritage Pharmaceuticals Inc. Recent Development
11.6 Ingenus Pharmaceuticals
11.6.1 Ingenus Pharmaceuticals Company Detail
11.6.2 Ingenus Pharmaceuticals Business Overview
11.6.3 Ingenus Pharmaceuticals Pseudotumor Cerebri Introduction
11.6.4 Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2017-2022)
11.6.5 Ingenus Pharmaceuticals Recent Development
11.7 Integra LifeSciences Corporation
11.7.1 Integra LifeSciences Corporation Company Detail
11.7.2 Integra LifeSciences Corporation Business Overview
11.7.3 Integra LifeSciences Corporation Pseudotumor Cerebri Introduction
11.7.4 Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2017-2022)
11.7.5 Integra LifeSciences Corporation Recent Development
11.8 Johnson & Johnson Services, Inc.
11.8.1 Johnson & Johnson Services, Inc. Company Detail
11.8.2 Johnson & Johnson Services, Inc. Business Overview
11.8.3 Johnson & Johnson Services, Inc. Pseudotumor Cerebri Introduction
11.8.4 Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.8.5 Johnson & Johnson Services, Inc. Recent Development
11.9 Lannett Company, Inc.
11.9.1 Lannett Company, Inc. Company Detail
11.9.2 Lannett Company, Inc. Business Overview
11.9.3 Lannett Company, Inc. Pseudotumor Cerebri Introduction
11.9.4 Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.9.5 Lannett Company, Inc. Recent Development
11.10 Magstim
11.10.1 Magstim Company Detail
11.10.2 Magstim Business Overview
11.10.3 Magstim Pseudotumor Cerebri Introduction
11.10.4 Magstim Revenue in Pseudotumor Cerebri Business (2017-2022)
11.10.5 Magstim Recent Development
11.11 Medtronic
11.11.1 Medtronic Company Detail
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Pseudotumor Cerebri Introduction
11.11.4 Medtronic Revenue in Pseudotumor Cerebri Business (2017-2022)
11.11.5 Medtronic Recent Development
11.12 MercuryPharma
11.12.1 MercuryPharma Company Detail
11.12.2 MercuryPharma Business Overview
11.12.3 MercuryPharma Pseudotumor Cerebri Introduction
11.12.4 MercuryPharma Revenue in Pseudotumor Cerebri Business (2017-2022)
11.12.5 MercuryPharma Recent Development
11.13 Nostrum Laboratories Inc.
11.13.1 Nostrum Laboratories Inc. Company Detail
11.13.2 Nostrum Laboratories Inc. Business Overview
11.13.3 Nostrum Laboratories Inc. Pseudotumor Cerebri Introduction
11.13.4 Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.13.5 Nostrum Laboratories Inc. Recent Development
11.14 Novast Holdings Ltd.
11.14.1 Novast Holdings Ltd. Company Detail
11.14.2 Novast Holdings Ltd. Business Overview
11.14.3 Novast Holdings Ltd. Pseudotumor Cerebri Introduction
11.14.4 Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.14.5 Novast Holdings Ltd. Recent Development
11.15 Phoenix Biomedical Corp.
11.15.1 Phoenix Biomedical Corp. Company Detail
11.15.2 Phoenix Biomedical Corp. Business Overview
11.15.3 Phoenix Biomedical Corp. Pseudotumor Cerebri Introduction
11.15.4 Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.15.5 Phoenix Biomedical Corp. Recent Development
11.16 Sanofi, SGPharma Pvt. Ltd.
11.16.1 Sanofi, SGPharma Pvt. Ltd. Company Detail
11.16.2 Sanofi, SGPharma Pvt. Ltd. Business Overview
11.16.3 Sanofi, SGPharma Pvt. Ltd. Pseudotumor Cerebri Introduction
11.16.4 Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.16.5 Sanofi, SGPharma Pvt. Ltd. Recent Development
11.17 Sophysa
11.17.1 Sophysa Company Detail
11.17.2 Sophysa Business Overview
11.17.3 Sophysa Pseudotumor Cerebri Introduction
11.17.4 Sophysa Revenue in Pseudotumor Cerebri Business (2017-2022)
11.17.5 Sophysa Recent Development
11.18 Taro Pharmaceutical Industries Ltd.
11.18.1 Taro Pharmaceutical Industries Ltd. Company Detail
11.18.2 Taro Pharmaceutical Industries Ltd. Business Overview
11.18.3 Taro Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
11.18.4 Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.18.5 Taro Pharmaceutical Industries Ltd. Recent Development
11.19 Teva Pharmaceutical Industries Ltd.
11.19.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.19.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.19.3 Teva Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
11.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.19.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.20 West-Ward Pharmaceutical
11.20.1 West-Ward Pharmaceutical Company Detail
11.20.2 West-Ward Pharmaceutical Business Overview
11.20.3 West-Ward Pharmaceutical Pseudotumor Cerebri Introduction
11.20.4 West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2017-2022)
11.20.5 West-Ward Pharmaceutical Recent Development
11.21 Zydus Pharmaceuticals, Inc.
11.21.1 Zydus Pharmaceuticals, Inc. Company Detail
11.21.2 Zydus Pharmaceuticals, Inc. Business Overview
11.21.3 Zydus Pharmaceuticals, Inc. Pseudotumor Cerebri Introduction
11.21.4 Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022)
11.21.5 Zydus Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pseudotumor Cerebri Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Fundoscopy
Table 3. Key Players of Neuroimaging
Table 4. Key Players of Lumbar Puncture
Table 5. Global Pseudotumor Cerebri Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pseudotumor Cerebri Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pseudotumor Cerebri Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Pseudotumor Cerebri Market Share by Region (2017-2022)
Table 9. Global Pseudotumor Cerebri Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Pseudotumor Cerebri Market Share by Region (2023-2028)
Table 11. Pseudotumor Cerebri Market Trends
Table 12. Pseudotumor Cerebri Market Drivers
Table 13. Pseudotumor Cerebri Market Challenges
Table 14. Pseudotumor Cerebri Market Restraints
Table 15. Global Pseudotumor Cerebri Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Pseudotumor Cerebri Market Share by Players (2017-2022)
Table 17. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudotumor Cerebri as of 2021)
Table 18. Ranking of Global Top Pseudotumor Cerebri Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Pseudotumor Cerebri Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pseudotumor Cerebri Product Solution and Service
Table 22. Date of Enter into Pseudotumor Cerebri Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pseudotumor Cerebri Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Pseudotumor Cerebri Revenue Market Share by Type (2017-2022)
Table 26. Global Pseudotumor Cerebri Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Pseudotumor Cerebri Revenue Market Share by Type (2023-2028)
Table 28. Global Pseudotumor Cerebri Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Pseudotumor Cerebri Revenue Market Share by Application (2017-2022)
Table 30. Global Pseudotumor Cerebri Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Pseudotumor Cerebri Revenue Market Share by Application (2023-2028)
Table 32. North America Pseudotumor Cerebri Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Pseudotumor Cerebri Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Pseudotumor Cerebri Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Pseudotumor Cerebri Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Pseudotumor Cerebri Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Pseudotumor Cerebri Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Pseudotumor Cerebri Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Pseudotumor Cerebri Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Pseudotumor Cerebri Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Pseudotumor Cerebri Market Size by Country (2023-2028) & (US$ Million)
Table 42. Avkare, Inc. Company Detail
Table 43. Avkare, Inc. Business Overview
Table 44. Avkare, Inc. Pseudotumor Cerebri Product
Table 45. Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 46. Avkare, Inc. Recent Development
Table 47. B. Braun Melsungen AG Company Detail
Table 48. B. Braun Melsungen AG Business Overview
Table 49. B. Braun Melsungen AG Pseudotumor Cerebri Product
Table 50. B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 51. B. Braun Melsungen AG Recent Development
Table 52. Beckersmith Medical, Inc. Company Detail
Table 53. Beckersmith Medical, Inc. Business Overview
Table 54. Beckersmith Medical, Inc. Pseudotumor Cerebri Product
Table 55. Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 56. Beckersmith Medical, Inc. Recent Development
Table 57. Elekta AB Company Detail
Table 58. Elekta AB Business Overview
Table 59. Elekta AB Pseudotumor Cerebri Product
Table 60. Elekta AB Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 61. Elekta AB Recent Development
Table 62. Heritage Pharmaceuticals Inc. Company Detail
Table 63. Heritage Pharmaceuticals Inc. Business Overview
Table 64. Heritage Pharmaceuticals Inc. Pseudotumor Cerebri Product
Table 65. Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 66. Heritage Pharmaceuticals Inc. Recent Development
Table 67. Ingenus Pharmaceuticals Company Detail
Table 68. Ingenus Pharmaceuticals Business Overview
Table 69. Ingenus Pharmaceuticals Pseudotumor Cerebri Product
Table 70. Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 71. Ingenus Pharmaceuticals Recent Development
Table 72. Integra LifeSciences Corporation Company Detail
Table 73. Integra LifeSciences Corporation Business Overview
Table 74. Integra LifeSciences Corporation Pseudotumor Cerebri Product
Table 75. Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 76. Integra LifeSciences Corporation Recent Development
Table 77. Johnson & Johnson Services, Inc. Company Detail
Table 78. Johnson & Johnson Services, Inc. Business Overview
Table 79. Johnson & Johnson Services, Inc. Pseudotumor Cerebri Product
Table 80. Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 81. Johnson & Johnson Services, Inc. Recent Development
Table 82. Lannett Company, Inc. Company Detail
Table 83. Lannett Company, Inc. Business Overview
Table 84. Lannett Company, Inc. Pseudotumor Cerebri Product
Table 85. Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 86. Lannett Company, Inc. Recent Development
Table 87. Magstim Company Detail
Table 88. Magstim Business Overview
Table 89. Magstim Pseudotumor Cerebri Product
Table 90. Magstim Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 91. Magstim Recent Development
Table 92. Medtronic Company Detail
Table 93. Medtronic Business Overview
Table 94. Medtronic Pseudotumor CerebriProduct
Table 95. Medtronic Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 96. Medtronic Recent Development
Table 97. MercuryPharma Company Detail
Table 98. MercuryPharma Business Overview
Table 99. MercuryPharma Pseudotumor CerebriProduct
Table 100. MercuryPharma Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 101. MercuryPharma Recent Development
Table 102. Nostrum Laboratories Inc. Company Detail
Table 103. Nostrum Laboratories Inc. Business Overview
Table 104. Nostrum Laboratories Inc. Pseudotumor CerebriProduct
Table 105. Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 106. Nostrum Laboratories Inc. Recent Development
Table 107. Novast Holdings Ltd. Company Detail
Table 108. Novast Holdings Ltd. Business Overview
Table 109. Novast Holdings Ltd. Pseudotumor CerebriProduct
Table 110. Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 111. Novast Holdings Ltd. Recent Development
Table 112. Phoenix Biomedical Corp. Company Detail
Table 113. Phoenix Biomedical Corp. Business Overview
Table 114. Phoenix Biomedical Corp. Pseudotumor CerebriProduct
Table 115. Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 116. Phoenix Biomedical Corp. Recent Development
Table 117. Sanofi, SGPharma Pvt. Ltd. Company Detail
Table 118. Sanofi, SGPharma Pvt. Ltd. Business Overview
Table 119. Sanofi, SGPharma Pvt. Ltd. Pseudotumor CerebriProduct
Table 120. Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 121. Sanofi, SGPharma Pvt. Ltd. Recent Development
Table 122. Sophysa Company Detail
Table 123. Sophysa Business Overview
Table 124. Sophysa Pseudotumor CerebriProduct
Table 125. Sophysa Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 126. Sophysa Recent Development
Table 127. Taro Pharmaceutical Industries Ltd. Company Detail
Table 128. Taro Pharmaceutical Industries Ltd. Business Overview
Table 129. Taro Pharmaceutical Industries Ltd. Pseudotumor CerebriProduct
Table 130. Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 131. Taro Pharmaceutical Industries Ltd. Recent Development
Table 132. Teva Pharmaceutical Industries Ltd. Company Detail
Table 133. Teva Pharmaceutical Industries Ltd. Business Overview
Table 134. Teva Pharmaceutical Industries Ltd. Pseudotumor CerebriProduct
Table 135. Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 136. Teva Pharmaceutical Industries Ltd. Recent Development
Table 137. West-Ward Pharmaceutical Company Detail
Table 138. West-Ward Pharmaceutical Business Overview
Table 139. West-Ward Pharmaceutical Pseudotumor CerebriProduct
Table 140. West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 141. West-Ward Pharmaceutical Recent Development
Table 142. Zydus Pharmaceuticals, Inc. Company Detail
Table 143. Zydus Pharmaceuticals, Inc. Business Overview
Table 144. Zydus Pharmaceuticals, Inc. Pseudotumor CerebriProduct
Table 145. Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2017-2022) & (US$ Million)
Table 146. Zydus Pharmaceuticals, Inc. Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudotumor Cerebri Market Share by Type: 2021 VS 2028
Figure 2. Fundoscopy Features
Figure 3. Neuroimaging Features
Figure 4. Lumbar Puncture Features
Figure 5. Global Pseudotumor Cerebri Market Share by Application in 2021 & 2028
Figure 6. Spinal Fluid Shunt Case Studies
Figure 7. Optic Nerve Sheath Fenestration Case Studies
Figure 8. Venous Sinus Stenting Case Studies
Figure 9. Medication Case Studies
Figure 10. Pseudotumor Cerebri Report Years Considered
Figure 11. Global Pseudotumor Cerebri Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pseudotumor Cerebri Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pseudotumor Cerebri Market Share by Region: 2021 VS 2028
Figure 14. Global Pseudotumor Cerebri Market Share by Players in 2021
Figure 15. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudotumor Cerebri as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pseudotumor Cerebri Revenue in 2021
Figure 17. North America Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Pseudotumor Cerebri Market Share by Country (2017-2028)
Figure 19. United States Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Pseudotumor Cerebri Market Share by Country (2017-2028)
Figure 23. Germany Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Pseudotumor Cerebri Market Share by Region (2017-2028)
Figure 31. China Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Pseudotumor Cerebri Market Share by Country (2017-2028)
Figure 39. Mexico Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Pseudotumor Cerebri Market Share by Country (2017-2028)
Figure 43. Turkey Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Pseudotumor Cerebri Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Avkare, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 46. B. Braun Melsungen AG Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 47. Beckersmith Medical, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 48. Elekta AB Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 49. Heritage Pharmaceuticals Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 50. Ingenus Pharmaceuticals Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 51. Integra LifeSciences Corporation Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 52. Johnson & Johnson Services, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 53. Lannett Company, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 54. Magstim Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 55. Medtronic Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 56. MercuryPharma Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 57. Nostrum Laboratories Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 58. Novast Holdings Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 59. Phoenix Biomedical Corp. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 60. Sanofi, SGPharma Pvt. Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 61. Sophysa Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 62. Taro Pharmaceutical Industries Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 64. West-Ward Pharmaceutical Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 65. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Avkare, Inc. B. Braun Melsungen AG Beckersmith Medical, Inc. Elekta AB Heritage Pharmaceuticals Inc. Ingenus Pharmaceuticals Integra LifeSciences Corporation Johnson & Johnson Services, Inc. Lannett Company, Inc. Magstim Medtronic MercuryPharma Nostrum Laboratories Inc. Novast Holdings Ltd. Phoenix Biomedical Corp. Sanofi, SGPharma Pvt. Ltd. Sophysa Taro Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. West-Ward Pharmaceutical Zydus Pharmaceuticals, Inc.